In the News

Breast Cancer, FDA Approvals, In the News, Multiple Myeloma, Pediatric Cancer, Select Drug Profiles

Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News

FDA on In Vitro Diagnostics, Vaping; Cost of Novel Treatments

FDA Approvals, Multiple Myeloma, In the News, Select Drug Profiles

FDA Approves Darzalex Combination for First-Line Treatment of Transplant-Eligible Patients with Multiple Myeloma

FDA Approvals, In the News, Select Drug Profiles

Keytruda Approved for Patients with Previously Treated Metastatic Small-Cell Lung Cancer

FDA Approvals, In the News, Select Drug Profiles

First Chemoimmunotherapy Regimen Granted Accelerated Approval for Patients with Previously Treated DLBCL

Breast Cancer, FDA Approvals, In the News, Select Drug Profiles

FDA Expands Indication for Kadcyla to Include the Adjuvant Treatment of HER2-Positive Early Breast Cancer

FDA Approvals, In the News, Select Drug Profiles

Tibsovo Now FDA Approved as First-Line Treatment for AML with IDH1 Mutation

FDA Approvals, In the News, Select Drug Profiles

FDA Approves Pembrolizumab plus Axitinib for Advanced Renal-Cell Carcinoma

FDA Approvals, In the News, Select Drug Profiles

April 16, 2019 – FDA Approvals, News & Updates

Breast Cancer, FDA Approvals, In the News, Select Drug Profiles

FDA Approves First Hormonal-Based Therapy for Men with Advanced or Metastatic Breast Cancer

1
2
3
4
5

Page 2 of 6
Results 11 - 20 of 60

SUBSCRIBE

Copyright © Amplity Medical Communications. All rights reserved.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Print Edition

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.